Share on StockTwits
 

Nu Skin Enterprises (NYSE:NUS) is scheduled to announce its Q413 earnings results on Monday, March 3rd. Analysts expect the company to announce earnings of $1.99 per share and revenue of $1.07 billion for the quarter. Parties interested in registering for the company’s conference call can do so using this link.

Shares of Nu Skin Enterprises (NYSE:NUS) opened at 84.52 on Friday. Nu Skin Enterprises has a 52-week low of $40.15 and a 52-week high of $140.50. The stock has a 50-day moving average of $87.32 and a 200-day moving average of $103.9. The company has a market cap of $5.027 billion and a price-to-earnings ratio of 16.89.

Several analysts have recently commented on the stock. Analysts at Ned Davis Research upgraded shares of Nu Skin Enterprises from a “neutral” rating to a “buy” rating in a research note on Monday. Finally, analysts at Sidoti reiterated a “buy” rating on shares of Nu Skin Enterprises in a research note on Monday, February 10th. Five equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $109.54.

Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.